rosiglitazone has been researched along with Amentia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tseng, CH | 1 |
Doblhammer, G; Fink, A; Heneka, MT | 1 |
2 other study(ies) available for rosiglitazone and Amentia
Article | Year |
---|---|
Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients.
Topics: Aged; Case-Control Studies; Dementia; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Risk Factors; Rosiglitazone | 2019 |
Effect of pioglitazone medication on the incidence of dementia.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Dementia; Diabetes Mellitus; Female; Germany; Humans; Hypoglycemic Agents; Incidence; Insulin; Male; Metformin; Middle Aged; Pioglitazone; Proportional Hazards Models; Prospective Studies; Protective Factors; Rosiglitazone; Thiazolidinediones | 2015 |